SRPT icon

Sarepta Therapeutics
SRPT

Overview Fund Activity

364 hedge funds and large institutions have $7.21B invested in Sarepta Therapeutics in 2020 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 124 increasing their positions, 129 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
364
Holders Change
-25
Holders Change %
-6.43%
% of All Funds
8.04%
Holding in Top 10
8
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-20%
% of All Funds
0.18%
New
51
Increased
124
Reduced
129
Closed
71
Calls
$172M
Puts
$209M
Net Calls
-$37M
Net Calls Change
-$219M

Top Buyers

1
Capital Research Global Investors
Capital Research Global Investors
California
+$143M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$91.7M
3
CCM
Consonance Capital Management
New York
+$45.7M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$34.6M
5
FCM
Farallon Capital Management
California
+$34.2M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$160M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$74.6M
3
CCM
Cadian Capital Management
New York
-$71M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$44.5M
5
BC
Boxer Capital
California
-$29M
Name Holding Trade Value Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$725M -$74.6M -762,451 -9%
Vanguard Group
2
Vanguard Group
Pennsylvania
$640M +$15.7M +160,001 +3%
BlackRock
3
BlackRock
New York
$478M +$24.2M +247,159 +5%
Sands Capital Management
4
Sands Capital Management
Virginia
$431M -$15.1M -154,568 -3%
Capital Research Global Investors
5
Capital Research Global Investors
California
$379M +$143M +1,465,905 +61%
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$345M +$34.6M +353,301 +11%
State Street
7
State Street
Massachusetts
$201M +$3.56M +36,383 +2%
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$198M +$91.7M +937,670 +86%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$165M -$160M -1,635,105 -49%
Ameriprise
10
Ameriprise
Minnesota
$157M +$20.1M +205,465 +15%
ACA
11
Avoro Capital Advisors
New York
$155M -$17.1M -175,000 -10%
Invesco
12
Invesco
Georgia
$152M -$24.5M -250,184 -14%
Goldman Sachs
13
Goldman Sachs
New York
$130M +$21.3M +217,352 +20%
JPMorgan Chase & Co
14
JPMorgan Chase & Co
New York
$112M +$20.3M +207,113 +22%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$111M -$1.74M -17,792 -2%
WRF
16
Waddell & Reed Financial
Kansas
$111M -$359K -3,668 -0.3%
EAM
17
Eventide Asset Management
Massachusetts
$97.4M – – –
Wellington Management Group
18
Wellington Management Group
Massachusetts
$92.5M -$560K -5,722 -0.6%
GGHC
19
Gilder Gagnon Howe & Co
New York
$90.8M -$1.52M -15,529 -2%
O
20
OrbiMed
New York
$88.3M +$13.3M +136,400 +18%
Deutsche Bank
21
Deutsche Bank
Germany
$84.8M -$12.8M -130,705 -13%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$83.2M +$6.25M +63,996 +8%
CCM
23
Consonance Capital Management
New York
$80.5M +$45.7M +467,020 +131%
Jennison Associates
24
Jennison Associates
New York
$75.9M +$578K +5,909 +0.8%
FAM
25
Fred Alger Management
New York
$73.7M -$10.8M -110,287 -13%
1
2 3 4 5